Join the Sutent group to help and get support from people like you.
Sutent News
FDA Approves Sutent (sunitinib malate) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
November 16, 2017 – The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell...
FDA Approves Sutent for Rare Type of Pancreatic Cancer
SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors...
Ask a question
To post your own question to this support group, sign in or create an account.